LIMO: Latent Inceptionism for Targeted Molecule Generation.

Peter Eckmann, Kunyang Sun, Bo Zhao, Mudong Feng, Michael K Gilson, Rose Yu
{"title":"LIMO: Latent Inceptionism for Targeted Molecule Generation.","authors":"Peter Eckmann,&nbsp;Kunyang Sun,&nbsp;Bo Zhao,&nbsp;Mudong Feng,&nbsp;Michael K Gilson,&nbsp;Rose Yu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Generation of drug-like molecules with high binding affinity to target proteins remains a difficult and resource-intensive task in drug discovery. Existing approaches primarily employ reinforcement learning, Markov sampling, or deep generative models guided by Gaussian processes, which can be prohibitively slow when generating molecules with high binding affinity calculated by computationally-expensive physics-based methods. We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique. LIMO employs a variational autoencoder-generated latent space and property prediction by two neural networks in sequence to enable faster gradient-based reverse-optimization of molecular properties. Comprehensive experiments show that LIMO performs competitively on benchmark tasks and markedly outperforms state-of-the-art techniques on the novel task of generating drug-like compounds with high binding affinity, reaching nanomolar range against two protein targets. We corroborate these docking-based results with more accurate molecular dynamics-based calculations of absolute binding free energy and show that one of our generated drug-like compounds has a predicted <i>K</i> <sub><i>D</i></sub> (a measure of binding affinity) of 6 · 10<sup>-14</sup> M against the human estrogen receptor, well beyond the affinities of typical early-stage drug candidates and most FDA-approved drugs to their respective targets. Code is available at https://github.com/Rose-STL-Lab/LIMO.</p>","PeriodicalId":74504,"journal":{"name":"Proceedings of machine learning research","volume":" ","pages":"5777-5792"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527083/pdf/nihms-1836710.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of machine learning research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Generation of drug-like molecules with high binding affinity to target proteins remains a difficult and resource-intensive task in drug discovery. Existing approaches primarily employ reinforcement learning, Markov sampling, or deep generative models guided by Gaussian processes, which can be prohibitively slow when generating molecules with high binding affinity calculated by computationally-expensive physics-based methods. We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique. LIMO employs a variational autoencoder-generated latent space and property prediction by two neural networks in sequence to enable faster gradient-based reverse-optimization of molecular properties. Comprehensive experiments show that LIMO performs competitively on benchmark tasks and markedly outperforms state-of-the-art techniques on the novel task of generating drug-like compounds with high binding affinity, reaching nanomolar range against two protein targets. We corroborate these docking-based results with more accurate molecular dynamics-based calculations of absolute binding free energy and show that one of our generated drug-like compounds has a predicted K D (a measure of binding affinity) of 6 · 10-14 M against the human estrogen receptor, well beyond the affinities of typical early-stage drug candidates and most FDA-approved drugs to their respective targets. Code is available at https://github.com/Rose-STL-Lab/LIMO.

Abstract Image

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
LIMO:靶向分子生成的潜在初始论。
在药物发现中,产生与靶蛋白具有高结合亲和力的类药物分子仍然是一项困难且资源密集型的任务。现有的方法主要采用强化学习、马尔可夫采样或由高斯过程指导的深度生成模型,当通过计算昂贵的基于物理的方法计算产生具有高结合亲和力的分子时,这些模型可能会非常缓慢。我们提出了分子的潜在初始化(LIMO),它通过类似于初始化的技术显著地加速了分子的生成。LIMO采用变分自编码器生成的潜在空间和由两个神经网络依次进行的性质预测,以实现更快的基于梯度的分子性质逆向优化。综合实验表明,LIMO在基准任务上具有竞争力,并且在产生具有高结合亲和力的药物样化合物的新任务上明显优于最先进的技术,达到纳摩尔范围针对两个蛋白质靶标。我们用更精确的基于分子动力学的绝对结合自由能计算证实了这些基于对接的结果,并表明我们生成的一种药物样化合物对人类雌激素受体的预测kd(结合亲和力的测量)为6·10-14 M,远远超过了典型的早期候选药物和大多数fda批准的药物对各自靶点的亲和力。代码可从https://github.com/Rose-STL-Lab/LIMO获得。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Contrastive Learning for Clinical Outcome Prediction with Partial Data Sources. Multi-Source Conformal Inference Under Distribution Shift. DISCRET: Synthesizing Faithful Explanations For Treatment Effect Estimation. Kernel Debiased Plug-in Estimation: Simultaneous, Automated Debiasing without Influence Functions for Many Target Parameters. Adapt and Diffuse: Sample-Adaptive Reconstruction Via Latent Diffusion Models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1